AGIOS PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
AGIOS PHARMACEUTICALS, INC. (AGIO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 168.23 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-07-30
- AGIOS PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 88.68K shares, a 67.28% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 79.55K shares, a 190.63% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 102.48K shares, a 212.18% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 90.05K shares, a 255.03% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 272.91K shares, a 244.36% increase from fiscal 2024.
- AGIOS PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 79.25K shares, a 93.17% decline from fiscal 2023.
- AGIOS PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 1.16M shares, a 34.79% increase from fiscal 2022.
- AGIOS PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 860.82K shares, a 48.13% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 88.68K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | 168.23K shares 10-Q · filed 2026-07-30 | 270.71K shares derived: sum of 3 quarters · filed 2026-07-30 | 360.76K shares derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | 79.55K shares 10-Q · filed 2026-04-29 | 182.03K shares derived: sum of 2 quarters · filed 2026-04-29 | 272.08K shares derived: sum of 3 quarters · filed 2026-04-29 | 325.09K shares derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-12-31 | 102.48K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | 192.53K shares derived: sum of 2 quarters · filed 2026-02-12 | 245.54K shares derived: sum of 3 quarters · filed 2026-02-12 | 272.91K shares 10-K · filed 2026-02-12 |
| 2025-09-30 | 90.05K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | 143.06K shares derived: sum of 2 quarters · filed 2025-10-30 | 170.44K shares 10-Q · filed 2025-10-30 | 203.26K shares derived: sum of 4 quarters · filed 2025-10-30 |
| 2025-06-30 | 53.01K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | 80.39K shares 10-Q · filed 2025-07-31 | 113.21K shares derived: sum of 3 quarters · filed 2025-07-31 | 138.57K shares derived: sum of 4 quarters · filed 2025-07-31 |
| 2025-03-31 | 27.37K shares 10-Q · filed 2025-05-01 | 60.20K shares derived: sum of 2 quarters · filed 2025-05-01 | 85.56K shares derived: sum of 3 quarters · filed 2025-05-01 | 97.27K shares derived: sum of 4 quarters · filed 2025-05-01 |
| 2024-12-31 | 32.83K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | 58.19K shares derived: sum of 2 quarters · filed 2025-02-13 | 69.90K shares derived: sum of 3 quarters · filed 2025-02-13 | 79.25K shares 10-K · filed 2025-02-13 |
| 2024-09-30 | 25.36K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | 37.07K shares derived: sum of 2 quarters · filed 2024-10-31 | 46.43K shares 10-Q · filed 2024-10-31 | 294.23K shares derived: sum of 4 quarters · filed 2024-10-31 |
| 2024-06-30 | 11.71K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | 21.06K shares 10-Q · filed 2024-08-01 | 268.86K shares derived: sum of 3 quarters · filed 2024-08-01 | 497.21K shares derived: sum of 4 quarters · filed 2024-08-01 |
| 2024-03-31 | 9.36K shares 10-Q · filed 2024-05-02 | 257.15K shares derived: sum of 2 quarters · filed 2024-05-02 | 485.50K shares derived: sum of 3 quarters · filed 2024-05-02 | 866.76K shares derived: sum of 4 quarters · filed 2024-05-02 |
| 2023-12-31 | 247.80K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | 476.15K shares derived: sum of 2 quarters · filed 2024-02-15 | 857.41K shares derived: sum of 3 quarters · filed 2024-02-15 | 1.16M shares 10-K · filed 2024-02-15 |
| 2023-09-30 | 228.35K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | 609.61K shares derived: sum of 2 quarters · filed 2023-11-02 | 912.48K shares 10-Q · filed 2023-11-02 | 1.06M shares derived: sum of 4 quarters · filed 2023-11-02 |
| 2023-06-30 | 381.26K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | 684.13K shares 10-Q · filed 2023-08-03 | 830.71K shares derived: sum of 3 quarters · filed 2023-08-03 | 1.08M shares derived: sum of 4 quarters · filed 2023-08-03 |
| 2023-03-31 | 302.87K shares 10-Q · filed 2023-05-04 | 449.45K shares derived: sum of 2 quarters · filed 2023-05-04 | 699.69K shares derived: sum of 3 quarters · filed 2023-05-04 | 995.54K shares derived: sum of 4 quarters · filed 2023-05-04 |
| 2022-12-31 | 146.58K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | 396.82K shares derived: sum of 2 quarters · filed 2023-02-23 | 692.67K shares derived: sum of 3 quarters · filed 2023-02-23 | 860.82K shares 10-K · filed 2023-02-23 |
| 2022-09-30 | 250.24K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | 546.09K shares derived: sum of 2 quarters · filed 2022-11-03 | 714.24K shares 10-Q · filed 2022-11-03 | 971.53K shares derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | 295.85K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 464.00K shares 10-Q · filed 2022-08-04 | 721.29K shares derived: sum of 3 quarters · filed 2022-08-04 | 909.99K shares derived: sum of 4 quarters · filed 2022-08-04 |
| 2022-03-31 | 168.15K shares 10-Q · filed 2022-05-05 | 425.44K shares derived: sum of 2 quarters · filed 2022-05-05 | 614.13K shares derived: sum of 3 quarters · filed 2022-05-05 | 1.12M shares derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-12-31 | 257.29K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | 445.99K shares derived: sum of 2 quarters · filed 2022-02-24 | 948.18K shares derived: sum of 3 quarters · filed 2022-02-24 | 1.66M shares 10-K · filed 2022-02-24 |
| 2021-09-30 | 188.69K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | 690.89K shares derived: sum of 2 quarters · filed 2021-11-03 | 1.40M shares 10-Q · filed 2021-11-03 | 1.66M shares derived: sum of 4 quarters · filed 2021-11-03 |
| 2021-06-30 | 502.19K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | 1.21M shares 10-Q · filed 2021-07-29 | 1.47M shares derived: sum of 3 quarters · filed 2021-07-29 | 1.67M shares derived: sum of 4 quarters · filed 2021-07-29 |
| 2021-03-31 | 711.34K shares 10-Q · filed 2021-04-29 | 964.20K shares derived: sum of 2 quarters · filed 2021-04-29 | 1.17M shares derived: sum of 3 quarters · filed 2021-04-29 | 1.30M shares derived: sum of 4 quarters · filed 2021-04-29 |
| 2020-12-31 | 252.86K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | 460.22K shares derived: sum of 2 quarters · filed 2021-02-25 | 590.86K shares derived: sum of 3 quarters · filed 2021-02-25 | 701.76K shares 10-K · filed 2021-02-25 |
| 2020-09-30 | 207.36K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | 338.00K shares derived: sum of 2 quarters · filed 2020-11-05 | 448.90K shares 10-Q · filed 2020-11-05 | 598.27K shares derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-06-30 | 130.64K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | 241.54K shares 10-Q · filed 2020-07-30 | 390.91K shares derived: sum of 3 quarters · filed 2020-07-30 | 588.92K shares derived: sum of 4 quarters · filed 2020-07-30 |
| 2020-03-31 | 110.90K shares 10-Q · filed 2020-04-30 | 260.28K shares derived: sum of 2 quarters · filed 2020-04-30 | 458.28K shares derived: sum of 3 quarters · filed 2020-04-30 | 631.25K shares derived: sum of 4 quarters · filed 2020-04-30 |
| 2019-12-31 | 149.37K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | 347.38K shares derived: sum of 2 quarters · filed 2020-02-19 | 520.34K shares derived: sum of 3 quarters · filed 2020-02-19 | 703.87K shares 10-K · filed 2020-02-19 |
| 2019-09-30 | 198.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | 370.97K shares derived: sum of 2 quarters · filed 2019-10-31 | 554.50K shares 10-Q · filed 2019-10-31 | 630.75K shares derived: sum of 4 quarters · filed 2019-10-31 |
| 2019-06-30 | 172.97K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | 356.49K shares 10-Q · filed 2019-08-01 | 432.74K shares derived: sum of 3 quarters · filed 2019-08-01 | 513.24K shares derived: sum of 4 quarters · filed 2019-08-01 |
| 2019-03-31 | 183.53K shares 10-Q · filed 2019-05-02 | 259.78K shares derived: sum of 2 quarters · filed 2019-05-02 | 340.27K shares derived: sum of 3 quarters · filed 2019-05-02 | 464.63K shares derived: sum of 4 quarters · filed 2019-05-02 |
| 2018-12-31 | 76.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | 156.75K shares derived: sum of 2 quarters · filed 2019-02-14 | 281.10K shares derived: sum of 3 quarters · filed 2019-02-14 | 383.23K shares 10-K · filed 2019-02-14 |
| 2018-09-30 | 80.49K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | 204.85K shares derived: sum of 2 quarters · filed 2018-11-01 | 306.98K shares 10-Q · filed 2018-11-01 | 475.57K shares derived: sum of 4 quarters · filed 2018-11-01 |
| 2018-06-30 | 124.36K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | 226.48K shares 10-Q · filed 2018-08-02 | 395.07K shares derived: sum of 3 quarters · filed 2018-08-02 | 524.16K shares derived: sum of 4 quarters · filed 2018-08-02 |
| 2018-03-31 | 102.13K shares 10-Q · filed 2018-05-04 | 270.72K shares derived: sum of 2 quarters · filed 2018-05-04 | 399.80K shares derived: sum of 3 quarters · filed 2018-05-04 | 557.72K shares derived: sum of 4 quarters · filed 2018-05-04 |
| 2017-12-31 | 168.59K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | 297.68K shares derived: sum of 2 quarters · filed 2018-02-14 | 455.59K shares derived: sum of 3 quarters · filed 2018-02-14 | 531.49K shares 10-K · filed 2018-02-14 |
| 2017-09-30 | 129.09K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | 287.00K shares derived: sum of 2 quarters · filed 2017-11-01 | 362.90K shares 10-Q · filed 2017-11-01 | 539.49K shares derived: sum of 4 quarters · filed 2017-11-01 |
| 2017-06-30 | 157.92K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | 233.82K shares 10-Q · filed 2017-08-08 | 410.41K shares derived: sum of 3 quarters · filed 2017-08-08 | 508.25K shares derived: sum of 4 quarters · filed 2017-08-08 |
| 2017-03-31 | 75.90K shares 10-Q · filed 2017-05-04 | 252.49K shares derived: sum of 2 quarters · filed 2017-05-04 | 350.33K shares derived: sum of 3 quarters · filed 2017-05-04 | 381.00K shares derived: sum of 4 quarters · filed 2017-05-04 |
| 2016-12-31 | 176.59K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | 274.43K shares derived: sum of 2 quarters · filed 2017-02-16 | 305.10K shares derived: sum of 3 quarters · filed 2017-02-16 | 352.70K shares 10-K · filed 2017-02-16 |
| 2016-09-30 | 97.84K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | 128.51K shares derived: sum of 2 quarters · filed 2016-11-03 | 176.11K shares 10-Q · filed 2016-11-03 | 217.47K shares derived: sum of 4 quarters · filed 2016-11-03 |
| 2016-06-30 | 30.67K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | 78.27K shares 10-Q · filed 2016-08-08 | 119.63K shares derived: sum of 3 quarters · filed 2016-08-08 | 128.39K shares derived: sum of 4 quarters · filed 2016-08-08 |
| 2016-03-31 | 47.60K shares 10-Q · filed 2016-05-09 | 88.96K shares derived: sum of 2 quarters · filed 2016-05-09 | 97.72K shares derived: sum of 3 quarters · filed 2016-05-09 | 135.25K shares derived: sum of 4 quarters · filed 2016-05-09 |
| 2015-12-31 | 41.36K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | 50.12K shares derived: sum of 2 quarters · filed 2016-02-26 | 87.65K shares derived: sum of 3 quarters · filed 2016-02-26 | 87.65K shares 10-K · filed 2016-02-26 |
| 2015-09-30 | 8.76K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | 46.28K shares derived: sum of 2 quarters · filed 2015-11-06 | 46.28K shares 10-Q · filed 2015-11-06 | 49.74K shares derived: sum of 4 quarters · filed 2015-11-06 |
| 2015-06-30 | 37.52K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | 37.52K shares 10-Q · filed 2015-08-07 | 40.98K shares derived: sum of 3 quarters · filed 2015-08-07 | 96.35K shares derived: sum of 4 quarters · filed 2015-08-07 |
| 2015-03-31 | 0.00 shares 10-Q · filed 2015-05-11 | 3.45K shares derived: sum of 2 quarters · filed 2015-05-11 | 58.82K shares derived: sum of 3 quarters · filed 2015-05-11 | 72.19K shares derived: sum of 4 quarters · filed 2015-05-11 |
| 2014-12-31 | 3.45K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | 58.82K shares derived: sum of 2 quarters · filed 2015-02-24 | 72.19K shares derived: sum of 3 quarters · filed 2015-02-24 | 81.46K shares 10-K · filed 2015-02-24 |
| 2014-09-30 | 55.37K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | 68.74K shares derived: sum of 2 quarters · filed 2014-11-07 | 78.00K shares 10-Q · filed 2014-11-07 | |
| 2014-06-30 | 13.37K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | 22.63K shares 10-Q · filed 2014-08-07 | ||
| 2014-03-31 | 9.27K shares 10-Q · filed 2014-05-09 | |||
| 2013-12-31 | 48.10K shares 10-K · filed 2014-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |